Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Daicel's Total Liabilities for the quarter that ended in Mar. 2026 was $2,921 Mil. Daicel's Total Assets for the quarter that ended in Mar. 2026 was $5,255 Mil.
Therefore, Daicel's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2026 was 0.56.
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.
Daicel Liabilities-to-Assets Related Terms
Daicel Liabilities-to-Assets Historical Data
* Premium members only.
The historical data trend for Daicel's Liabilities-to-Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DACHF vs LIN, SHW, ECL: Liabilities-to-Assets Comparison
For the Specialty Chemicals subindustry, Daicel's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Daicel Liabilities-to-Assets vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Daicel's Liabilities-to-Assets distribution charts can be found below:
* The bar in red indicates where Daicel's Liabilities-to-Assets falls into.
Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.
Daicel's Liabilities-to-Assets Ratio for the fiscal year that ended in Mar. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Daicel (DACHF) has a Liabilities-to-Assets of 0.56 as of Mar. 2026. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Daicel and its competitors.
Is Daicel's Liabilities-to-Assets too high?
Daicel's current Liabilities-to-Assets is 0.56. Overall, Daicel has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Daicel's Liabilities-to-Assets compare to LIN and SHW?
Daicel's Liabilities-to-Assets of 0.56 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Liabilities-to-Assets for a Chemicals company?
A good Liabilities-to-Assets depends on the Chemicals industry context. However, Liabilities-to-Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Liabilities-to-Assets mean?
A high Liabilities-to-Assets can signal that a stock is expensive relative to its fundamentals. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Daicel and its competitors. Daicel's current Liabilities-to-Assets is 0.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daicel stock overvalued right now?
Daicel (DACHF) has a current Liabilities-to-Assets of 0.56. The stock's GF Value™ is $8.03, compared to a current price of $8.00 — trading 0.4% below its estimated fair value. The current Liabilities-to-Assets is 0.56. Daicel's overall GF Score™ is 84/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Liabilities-to-Assets calculated?
Liabilities-to-Assets is calculated from a company's financial statements. For Daicel (DACHF), the current Liabilities-to-Assets is 0.56 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Daicel (DACHF) Overvalued in 2026?
Based on GuruFocus' analysis, Daicel stock appears to be undervalued.
The current stock price of $8.00 is trading 0.4% below its estimated GF Value™ of $8.03.
Key valuation signals for DACHF:
Liabilities-to-Assets: 0.56
GF Value™: $8.03 vs. price of $8.00 (0.4% below fair value)
No single metric tells the full story. See the DACHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Daicel Corp is a Japanese chemical company engaged in engineering plastics, materials, medical health care, safety, smart materials, & other businesses. The company operates through five segments. The Engineering Plastics segment includes polyacetal resins, PET resins, liquid crystal polymers, and related products. The Material segment covers acetic acid, derivatives, acetate tow, cellulose acetate, and cosmetic raw materials. The Medical Health Care segment provides enantiomer separation columns and health food materials. The Safety segment offers inflators for automobile airbags and circuit breakers, while the Smart segment handles caprolactone derivatives, epoxy compounds, semiconductor materials, and functional films. The Others segment includes membranes and transportation warehouses.
84GF Score
Get the complete analysis for DACHF
Liabilities-to-Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DACHF has been successfully added to your 
